Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank92
5Y CAGR+7.2%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+7.2%/yr
Long-term compound
Percentile
P92
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 28.34% |
| 2024 | -35.62% |
| 2023 | 8.83% |
| 2022 | -156.20% |
| 2021 | 53.72% |
| 2020 | 20.00% |
| 2019 | -54.81% |
| 2018 | -89.68% |
| 2017 | 18.71% |
| 2016 | -42.20% |